Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation

作者: Xiao-Ping Zhou , Oliver Gimm , Heather Hampel , Theodore Niemann , Michael J. Walker

DOI: 10.1016/S0002-9440(10)64627-5

关键词:

摘要: A tumor suppressor gene at 10q 23.3, designated PTEN, encoding a dual specificity phosphatase with lipid and protein activity, has been shown to play an important role in the pathogenesis of variety human cancers. Germline mutations PTEN cause Cowden syndrome (CS), which is characterized by multiple hamartomas high risk breast thyroid Frequent loss heterozygosity found both early advanced-stage sporadic melanomas; however, or deletions are detected mainly melanoma cell lines. In this study, we examined expression 34 unselected melanomas (4 primary melanomas, 30 metastases) using immunohistochemistry correlated results structural studies gene. Immunostaining samples revealed no 5 (15%) low 17 (50%), whereas rest tumors (35%) had levels expression. Hemizygous deletion was 32% but neither intragenic mutation nor biallelic any samples. Of showing expression, 4 PTEN. 13 having weak immunoreactivity informative results, 6 evidence hemizygous allelic while remaining 7 intact These strongly support as major on involved tumorigenesis suggest epigenetic mechanism functional inactivation not previously observed other cancers where might be involved.

参考文章(42)
H-J. Su Huang, Webster K. Cavenee, Frank B. Furnari, The Phosphoinositol Phosphatase Activity of PTEN Mediates a Serum-sensitive G1 Growth Arrest in Glioma Cells Cancer Research. ,vol. 58, pp. 5002- 5008 ,(1998)
Karen C. Arden, Rudolf A. Herbst, Jürgen Weiss, Webster K. Cavenee, Alexander Ehnis, Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Research. ,vol. 54, pp. 3111- 3114 ,(1994)
Jacqueline A. Lees, Elad Gil, Liang Ping Weng, Charis Eng, Charis Eng, Patricia L M Dahia, Wendy M. Smith, Ulrike Ziebold, PTEN Suppresses Breast Cancer Cell Growth by Phosphatase Activity-dependent G1 Arrest followed by Cell Death Cancer Research. ,vol. 59, pp. 5808- 5814 ,(1999)
Marian S. Blazes, Kathleen R. Cho, Steven I. Wang, Ramon Parsons, Shikha Bose, Lora Hedrick Ellenson, Hironori Tashiro, Jing Li, Rong Wu, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research. ,vol. 57, pp. 3935- 3940 ,(1997)
Bert Vogelstein, Kenneth W. Kinzler, The Genetic Basis of Human Cancer ,(1997)
Samar Jasser, W. K.Alfred Yung, Amy Berson, Diana Iliev, Carmen Tornos, Gregory Fujii, Gordon B. Mills, Lee Ellis, Marsha Frazier, Lauren A. Langford, Peter A. Steck, Thaylon Davis, Brad Swedlund, Patricia Troncoso, Cheryl Frye, David H.F. Teng, Raphael E. Pollack, Kipp L. Hansen, Rong Hu, Mark A. Pershouse, Jeff Lee, Adel El-Naggar, Robert Bookstein, Kathryn L. Gumpper, Huai Lin, Scan V. Tavtigian, Vickie L. Vinson, Joseph B. Bolen, MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Research. ,vol. 57, pp. 5221- 5225 ,(1997)
Paul Komminoth, Jan Zedenius, Tony Frisk, Charis Eng, Charis Eng, Debbie J. Marsh, Ramon Parsons, Michel Longy, Zimu Zheng, Patricia L M Dahia, Goran Wallin, Catharina Larsson, Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors Cancer Research. ,vol. 57, pp. 4710- 4713 ,(1997)
Lauri A. Aaltonen, Lauri A. Aaltonen, Sapna Syngal, Ilmo Kellokumpu, Walter F. Bodmer, Walter F. Bodmer, Akseli Hemminki, Kay Neale, Malcolm G. Dunlop, Diana Eccles, David Markie, David Markie, Sally E. Cottrell, Robin Phillips, Charis Eng, Charis Eng, Shirley V. Hodgson, Debbie J. Marsh, Stina Roth, Ian P M Tomlinson, Ian P M Tomlinson, Ian P M Tomlinson, Paul Rozen, Pertti Sistonen, Nathalie J. Van Orsouw, Zimu Zheng, Patricia L M Dahia, Stacey Caron, Jan Vijg, Heikki Järvinen, Kathryn L. Lunetta, Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Research. ,vol. 57, pp. 5017- 5021 ,(1997)
Faina Bogomolniy, Esther Rhei, Patrick I. Borgen, Lan Kang, Mark G. Federici, Jeff Boyd, Mutation Analysis of the Putative Tumor Suppressor Gene PTEN/MMAC1 in Primary Breast Carcinomas Cancer Research. ,vol. 57, pp. 3657- 3659 ,(1997)
V. Ahrenkiel, P. Guldberg, A. F. Kirkin, A. Birck, J. Zeuthen, P. Thor Straten, Disruption of the MMAC1/PTEN Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma Cancer Research. ,vol. 57, pp. 3660- 3663 ,(1997)